Inovio Pharmaceuticals (FRA:GBM) Short-Term Capital Lease Obligation : €1.98 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Inovio Pharmaceuticals Short-Term Capital Lease Obligation?

Inovio Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.98 Mil.

Inovio Pharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€1.99 Mil) to Dec. 2023 (€2.21 Mil) but then declined from Dec. 2023 (€2.21 Mil) to Mar. 2024 (€1.98 Mil).

Inovio Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€2.31 Mil) to Dec. 2022 (€2.65 Mil) but then declined from Dec. 2022 (€2.65 Mil) to Dec. 2023 (€2.21 Mil).

Inovio Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Inovio Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Short-Term Capital Lease Obligation Chart

Inovio Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.87

1.91

2.31

2.65

2.21

Inovio Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															2.41	2.17	1.99	2.21	1.98

Inovio Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Inovio Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Inovio Pharmaceuticals (FRA:GBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

INO:USA INO:Mexico

Address

660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462

Website

https://www.inovio.com

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals (FRA:GBM) Headlines

No Headlines